FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Conjugated Estrogens/Bazedoxifene (DUAVEE) Tablet, Film Coated
Status: Currently in Shortage
»Date first posted: 09/21/2022
»Therapeutic Categories: Reproductive

Expand all

Pfizer Pharmaceuticals (Reverified 03/17/2023)

Company Contact Information:
800-533-4535

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Conjugated estrogens 0.45 mg/bazedoxifene 20 mg; 2 blisters of 15 each (NDC 0008-1123-12)	Next Delivery and Estimated Recovery: Q4 2023	Shortage per Manufacturer: Manufacturing Delay	Other
Conjugated estrogens 0.45 mg/bazedoxifene 20 mg; blister of 7 each (US Sample) (NDC 63539-122-07)	Next Delivery and Estimated Recovery: Q4 2023	Shortage per Manufacturer: Manufacturing Delay	Other